Matinas BioPharma Holdings, Inc. (MTNB)
After hours:
| Previous close | 0.1833 |
| Open | 0.1887 |
| Bid | 0.1749 x 1000 |
| Ask | 0.1750 x 1400 |
| Day's range | 0.1748 - 0.1867 |
| 52-week range | 0.1100 - 0.8900 |
| Volume | |
| Avg. volume | 1,624,208 |
| Market cap | 43.868M |
| Beta (5Y monthly) | 1.55 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Matinas BioPharma Holdings, Inc. (AMEX:MTNB) Q4 2023 Earnings Call Transcript
Matinas BioPharma Holdings, Inc. (AMEX:MTNB) Q4 2023 Earnings Call Transcript March 28, 2024 Matinas BioPharma Holdings, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome, everyone, to the Matinas BioPharma 2023 Financial Results Conference Call. Currently, all participants are […]
- Thomson Reuters StreetEvents
Q4 2023 Matinas BioPharma Holdings Inc Earnings Call
Q4 2023 Matinas BioPharma Holdings Inc Earnings Call
- Insider Monkey
Matinas BioPharma Holdings, Inc. (AMEX:MTNB) Q3 2023 Earnings Call Transcript
Matinas BioPharma Holdings, Inc. (AMEX:MTNB) Q3 2023 Earnings Call Transcript November 8, 2023 Matinas BioPharma Holdings, Inc. reports earnings inline with expectations. Reported EPS is $-0.03 EPS, expectations were $-0.03. Operator: Welcome to the Matinas BioPharma Third Quarter 2023 Financial Results Conference Call. Currently, all participants are in a listen-only mode. Following management’s prepared remarks, […]
